Buy Lys-MDA (N-(L-lysinamidyl) Cas 1391487-26-5
Buy Lys-MDA (N-(L-lysinamidyl) Cas 1391487-26-5
Lys-MDA, or lysine-MDA, also known as N-(L-lysinamidyl)-MDA, is an entactogen of the phenethylamine, amphetamine, and MDxx families with entactogenic effects, which acts as a prodrug for MDA with a somewhat slower onset of effects and longer duration of action.[1] Lys-MDA, along with the related derivative Lys-MDMA, are in early stage human clinical trials as potential treatments for treatment-resistant depression and post-traumatic stress disorder. New MDMA prodrugs are in the development phase at MiHKAL GmbH in Switzerland.[2][3][4][5] A phase 1 clinical trial comparing MDMA, MDA, Lys-MDMA, and Lys-MDA has been completed as of August 2024.[6] The trial results, which included pharmacodynamic and pharmacokinetic findings, was published in September 2025.[1]
Interactions
Hexanamide, 2,6-diamino-N-[2-(1,3-benzodioxol-5-yl)-1-methylethyl]-, (2S)-
|
|
Hexanamide, 2,6-diamino-N-[2-(1,3-benzodioxol-5-yl)-1-methylethyl]-, (2S)- Eigenschaften
- Siedepunkt:
- 543.5±50.0 °C(Predicted)
- Dichte
- 1.168±0.06 g/cm3(Predicted)
- pka
- 14.92±0.46(Predicted)
Buy Lys-MDA (N-(L-lysinamidyl) Cas 1391487-26-5
Buy Lys-MDA (N-(L-lysinamidyl) Cas 1391487-26-5
Buy Lys-MDA (N-(L-lysinamidyl) Cas 1391487-26-5
Buy Lys-MDA (N-(L-lysinamidyl) Cas 1391487-26-5
Buy Lys-MDA (N-(L-lysinamidyl) Cas 1391487-26-5
Buy Lys-MDA (N-(L-lysinamidyl) Cas 1391487-26-5
Buy Lys-MDA (N-(L-lysinamidyl) Cas 1391487-26-5
Buy Lys-MDA (N-(L-lysinamidyl) Cas 1391487-26-5
Buy Lys-MDA (N-(L-lysinamidyl) Cas 1391487-26-5
Buy Lys-MDA (N-(L-lysinamidyl) Cas 1391487-26-5
Buy Lys-MDA (N-(L-lysinamidyl) Cas 1391487-26-5
Buy Lys-MDA Cas 1391487-26-5
Buy Lys-MDA Cas 1391487-26-5
Lys-MDA, or lysine-MDA, also known as N-(L-lysinamidyl)-MDA, is an entactogen of the phenethylamine, amphetamine, and MDxx families with entactogenic effects, which acts as a prodrug for MDA with a somewhat slower onset of effects and longer duration of action.[1] Lys-MDA, along with the related derivative Lys-MDMA, are in early stage human clinical trials as potential treatments for treatment-resistant depression and post-traumatic stress disorder. New MDMA prodrugs are in the development phase at MiHKAL GmbH in Switzerland.[2][3][4][5] A phase 1 clinical trial comparing MDMA, MDA, Lys-MDMA, and Lys-MDA has been completed as of August 2024.[6] The trial results, which included pharmacodynamic and pharmacokinetic findings, was published in September 2025.[1]
Interactions
Hexanamide, 2,6-diamino-N-[2-(1,3-benzodioxol-5-yl)-1-methylethyl]-, (2S)- Chemische Eigenschaften,Einsatz,Produktion Methoden
Hexanamide, 2,6-diamino-N-[2-(1,3-benzodioxol-5-yl)-1-methylethyl]-, (2S)- Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
-
Buy Lys-MDA Cas 1391487-26-5 – Cas 1391487-26-5 Buy
Lys-MDA, along with the related derivative Lys-MDMA, are in early stage human clinical trials as potential treatments for treatment …
-
Lys-MDA | C16H25N3O3 | CID 177841565 – PubChem
Lys-MDA | C16H25N3O3 | CID 177841565 – structure, chemical names, physical and chemical properties, …
-
Hexanamide, 2,6-diamino-N- [2- (1,3-benzodioxol-5-yl)-1-methylethyl …
Hexanamide, 2,6-diamino-N- [2- (1,3-benzodioxol-5-yl)-1-methylethyl]-, (2S)-,,1391487-26-5,,C16H25N3O3
-
Lys-MDA – Wikipedia
Lys-MDA – Wikipedia. Jump to content. Main menu. move to sidebarhide. Navigation . Main page. Contents. Current events. …
-
Hexanamide, 2,6-diamino-N-[2-(1,3-benzodioxol-5-yl)-1-methylethyl …
Hexanamide, 2,6-diamino-N- [2- (1,3-benzodioxol-5-yl)-1-methylethyl]-, (2S)- (CAS 1391487-26-5) information, including chemical …
-
N-(L-Lysinamidyl)-3,4-methylenedioxyamphetamine – Wikipedia
In other projects Appearance move to sidebar hide Lys-MDA
-
Chemistry:Lys-MDA – HandWiki
Lys-MDA (Lysine-MDA, N- (L-lysinamidyl)-3,4-methylenedioxyamphetamine) is a substituted amphetamine derivative …
-
Hexanamide, 2,6-diamino-N- [2- (1,3-benzodioxol-5-yl)-1-methylethyl …
You can also browse global suppliers,vendor,prices,Price,manufacturers of Hexanamide, 2,6-diamino-N- [2- (1,3-benzodioxol-5-yl)-1 …
-
Lys-MDA – Wikiwand
Lys-MDA (Lysine-MDA, N- (L-lysinamidyl)-3,4-methylenedioxyamphetamine) is a substituted amphetamine derivative …
-
Lys-MDA – Wikiwand
Lys-MDA, along with the related derivative Lys-MDMA, are in early stage human clinical trials as potential treatments for treatment …


![Hexanamide, 2,6-diamino-N-[2-(1,3-benzodioxol-5-yl)-1-methylethyl]-, (2S)- Struktur](https://www.chemicalbook.com/CAS/20210305/GIF/1391487-26-5.gif)







Reviews
There are no reviews yet.